Mark Sirgo

RDD Pharma Ltd. develops pharmacological treatments for diseases of the anorectal region. The company was founded by Nir Barak in 2008 and is headquartered in Ramat Hachayal, Israel.

Corium Pharma Solutions, Inc. is a full-service contract development and manufacturing organization that specializes in novel drug and consumer product delivery technologies. The company is based in an undisclosed location. The American company offers end-to-end solutions to its partners, from formulation and product development work, through commercial-scale manufacturing and packaging. Corium Pharma Solutions has a track record spanning nearly 30 years and is jointly owned by B-Flexion and Webster Equity Partners. The company's success is enabled by its state-of-the-art facilities, highly tenured operational leadership, and proprietary drug delivery technologies, Corplex™ and MicroCor®. Mark A. Sirgo has been the CEO of the company since 2023.

Arius Pharmaceuticals, Inc. develops pharmaceuticals for surgical and oncology patients. The firm offers treatments for rapid, oral delivery of sedation, and pain relief of surgical and oncology patients. The firm was founded by Andrew Finn and Mark A. Sirgo in 2003 and is located in Morrisville, NC

Pharmaceutical Product Development LLC engages in the operation of a global contract research organization, which provides drug development, laboratory and lifecycle management services. It offers adaptive trial design, bio analytical lab, bio similar development, biostatistics, GMP lab, clinical supplies, trial monitoring, CMC regulatory, data management, dental pain clinic, real-world outcomes, site intelligence and activation, central lab, global regulatory affairs, IRT systems, late stage research, medical communications, device and diagnostics, medical writing, nonclinical development and regulatory consulting and intelligence, regulatory development, innovation and vaccine sciences. The company was founded by Fredric N. Eshelman in 1985 and is headquartered in Wilmington, NC.